The value of observational registry studies for the next infectious disease emergency
oleh: Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, Michael J. Joyner
| Format: | Article |
|---|---|
| Diterbitkan: | American Society for Microbiology 2023-12-01 |
Deskripsi
ABSTRACTDuring infectious disease emergencies, it may be necessary to deploy new therapies without conclusive evidence for their effectiveness. During the SARS-CoV-2 pandemic, several countries used registries to track the use of COVID-19 convalescent plasma (CCP). Those registries provided evidence that CCP was effective when used early and with high titer.